Gammaferon – DIVA Trademark (Class 1) — Ready for Examination Status & Details

The current status of Gammaferon – DIVA is "Ready for Examination". It was filed on 06/11/2026 at CHENNAI in Class 1. Status may change over time as the application moves through examination, publication, opposition and registration stages.

Gammaferon – DIVA is filed in Class 1, covering: Reagents in kit form for conducting enzyme-linked immunosorbent assays (elisa) [other than for medical or veterinary purposes; Diagnostic reagents for scientific use; Reagents used in science; Reagents for scientific purposes; Reagents for medical research; Reagents for chemical analyses; Clinical diagnostics, other than for medical or veterinary use; Reagents used for analytical moisture determinations; Chemical reagents for genetic identity testing; Genetic identity tests comprised of reagents; Reagents for use in immunoserology; Diagnostic reagents for scientific use; Chemical reagents for scientific purposes; Antibody reagents for scientific purposes; Diagnostic reagents, except for medical or veterinary use; Insemination result control diagnosis reagents [for scientific use]; Cell culture reagents for scientific and research use; In-vivo diagnostic reagents for scientific use; Immunoassay reagents, other than for medical use; Reagents used for analytical moisture determinations; Reagents for testing the sterility of pharmaceuticals and injectable solutions; Reagents for use in scientific apparatus for chemical or biological analysis; Diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology.

Gammaferon – DIVA covers: Reagents in kit form for conducting enzyme-linked immunosorbent assays (elisa) [other than for medical or veterinary purposes; Diagnostic reagents for scientific use; Reagents used in science; Reagents for scientific purposes; Reagents for medical research; Reagents for chemical analyses; Clinical diagnostics, other than for medical or veterinary use; Reagents used for analytical moisture determinations; Chemical reagents for genetic identity testing; Genetic identity tests comprised of reagents; Reagents for use in immunoserology; Diagnostic reagents for scientific use; Chemical reagents for scientific purposes; Antibody reagents for scientific purposes; Diagnostic reagents, except for medical or veterinary use; Insemination result control diagnosis reagents [for scientific use]; Cell culture reagents for scientific and research use; In-vivo diagnostic reagents for scientific use; Immunoassay reagents, other than for medical use; Reagents used for analytical moisture determinations; Reagents for testing the sterility of pharmaceuticals and injectable solutions; Reagents for use in scientific apparatus for chemical or biological analysis; Diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology.

The exact word "Gammaferon – DIVA" is already on record at the Indian Trademark Registry under Application No. 8112164. If you intend to use a similar mark for similar goods or services, you should conduct a comprehensive availability search and consult a trademark attorney before filing. Registerkaro offers a free availability check followed by professional filing.

Indian registered trademarks are valid for 10 years from the date of registration and can be renewed indefinitely in 10-year blocks. Gammaferon – DIVA (App #8112164) is currently in status "Ready for Examination" — renewal dates apply only after registration is granted.

If Gammaferon – DIVA is in the "Advertised before Acceptance" or "Accepted & Advertised" stage, you have a 4-month window from publication in the Trade Marks Journal to file an opposition (Form TM-O) at the same Trade Marks Registry office. Grounds typically include prior rights, descriptiveness or bad faith. Registerkaro can prepare and file a Notice of Opposition for you.